Delphicort
Delphicort Brand names, Delphicort Analogs
- Adcortyl
- Aristocort
- Aristocort A
- Aristocort Tablets
- Aristogel
- Aristospan
- Azmacort
- Celeste
- Cinolone
- Cinolone-T
- Delphicort
- Fluoxiprednisolone
- Fluoxyprednisolone
- Flutex
- Kenacort
- Kenacort-A
- Kenacort-Ag
- Kenalog
- Kenalog in Orabase
- Kenalog-10
- Kenalog-40
- Kenalog-H
- Ledercort
- Nasacort
- Nasacort Aq
- Nasacort Hfa
- Omcilon
- Omicilon
- Oracort
- Oralone
- Orion
- Polcortolon
- Rodinolone
- Sk-Triamcinolone
- Tiamcinolonum [Inn-Latin]
- Tri-Nasal
- Triacet
- Triacort
- Triam-Tablinen
- Triamcet
- Triamcinalone
- Triamcinlon
- Triamcinolon
- Triamcinolona [Inn-Spanish]
- Triamcinolone Acetonide
- Triamcinolone Acetonide in Absorbase
- Triamcinolone Diacetate
- Triamcinolone [Usan:Ban:Inn:Jan]
- Triamcinolonum [Inn]
- Triatex
- Tricortale
- Triderm
- Trymex
- Vetalog
- Volon
Delphicort Brand Names Mixture
- Aristoform R Crm 0.1% (Clioquinol + Triamcinolone Acetonide)
- Derma-4 Ont (Neomycin Sulfate + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
- Kenacomb Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
- Kenacomb Mild Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
- Kenacomb Mild Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
- Kenacomb Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
- Kenacomb Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Mecomb Crm 0.1% (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Oribiotic Ointment (Bacitracin + Lidocaine + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Panolog Cream (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
- Panolog Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
- Ratio-Triacomb Regular Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Solvaderm Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
- Theraderm Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Viaderm Kc Crm (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
- Viaderm Kc Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
Delphicort Chemical_Formula
Delphicort RX_link
Delphicort fda sheet
Delphicort msds (material safety sheet)
Delphicort Synthesis Reference
Delphicort Molecular Weight
Delphicort Melting Point
Delphicort H2O Solubility
Delphicort State
Delphicort LogP
Delphicort Dosage Forms
Delphicort Indication
Delphicort Pharmacology
Delphicort Absorption
Delphicort side effects and Toxicity
Delphicort Patient Information
Patients being treated with Azmacort Inhalation Aerosol should receive the following information and instructions. This information is intended to aid them in the safe and effective use of this medication. It is not a complete disclosure of all possible adverse or intended effects.
Patients should use Azmacort Inhalation Aerosol at regular intervals as directed. Results of clinical trials indicate that significant improvement in asthma may occur by 1 week, but maximum benefit may not be achieved for 2 weeks or more. The patient should not increase the prescribed dosage but should contact the physician if symptoms do not improve or if the condition worsens.
In clinical studies and post-marketing experience with Azmacort Inhalation Aerosol, local infections of the oropharynx with Candida albicans have occurred. When such an infection develops, it should be treated with appropriate local or systemic (i.e., oral antifungal) therapy while remaining on treatment with Azmacort Inhalation Aerosol. However, at times therapy with Azmacort Inhalation Aerosol may need to be interrupted.
Patients should be instructed to track their use of Azmacort Inhalation Aerosol and to dispose of the canister after 240 actuations since reliable dose delivery cannot be assured after 240 doses.
Patients who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or measles and if exposed, to obtain medical advice.
